Melinda Gooderham
- Dermatology top 0.02%
- Immunology top 0.2%
- Rheumatology top 0.5%
- Immunology and Allergy top 0.2%
- Physiology top 1%
- Co-authors
- Kim PappAndrew BlauveltKristian ReichDiamant ThaçiMark LebwohlRobert BissonnetteYves PoulinPanteha Eshtiaghi
- Topics
- Dermatology and Skin Diseases (190 papers)Psoriasis: Treatment and Pathogenesis (173 papers)Allergic Rhinitis and Sensitization (61 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Melinda Gooderham
315 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Dermatology 5.0k
- Immunology 4.9k
- Rheumatology 1.7k
- Immunology and Allergy 1.6k
- Physiology 1.5k
Countries citing papers authored by Melinda Gooderham
This map shows the geographic impact of Melinda Gooderham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda Gooderham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda Gooderham more than expected).
Fields of papers citing papers by Melinda Gooderham
This network shows the impact of papers produced by Melinda Gooderham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda Gooderham. The network helps show where Melinda Gooderham may publish in the future.
Co-authorship network of co-authors of Melinda Gooderham
This figure shows the co-authorship network connecting the top 25 collaborators of Melinda Gooderham. A scholar is included among the top collaborators of Melinda Gooderham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda Gooderham. Melinda Gooderham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 27 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 15 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 30 | |
| 14 | Topical Roflumilast for Plaque Psoriasis. | 5 |
| 15 | 6 | |
| 16 | Selective TYK2 Inhibition in the Treatment of Moderate to Severe Chronic Plaque Psoriasis | 0 |
| 17 | 1 | |
| 18 | 1 | |
| 19 | Topical tofacitinib for atopic dermatitis: a phase | 320 |
| 20 | 2 |
About Melinda Gooderham
Melinda Gooderham is a scholar working on Dermatology, Immunology and Allergy and Immunology, having authored 350 papers that have together received 8.6k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (190 papers), Psoriasis: Treatment and Pathogenesis (173 papers) and Allergic Rhinitis and Sensitization (61 papers). The work is most often cited by research in Dermatology (5.0k citations), Immunology and Allergy (1.6k citations) and Immunology (4.9k citations). Melinda Gooderham has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Kim Papp, Andrew Blauvelt, Kristian Reich, Diamant Thaçi, Mark Lebwohl, Robert Bissonnette, Yves Poulin, Panteha Eshtiaghi, Charles Lynde and C. Paul. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.